Tevogen Updates on Development of EBV-Specific T Cell Therapy with Support from AI-Powered Target Discovery
WARREN, N.J., June 18, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today provided an...
Cancer
IMUNON Presents Positive Phase 2 Translational Data of IMNN-001 in Advanced Ovarian Cancer at ESMO Gynaecological Cancers Congress 2025
ASCO 2025 overall survival data bolster IMNN-001’s potential in advanced ovarian cancer, supported by robust translational results at ESMO Results...
Pacira BioSciences Debuts Inspiring New Film Highlighting One Patient’s Journey to Pain Relief and Innovation in Care at BIO 2025
- Produced for Pacira by BBC StoryWorks Commercial Productions, The Next Frontier: Mark & Leah’s Story Highlights the Impact of...
Prenetics Divests ACT Genomics to Delta Electronics as Part of up to US$71.78 Million Transaction
Bolsters Prenetics’ pro-forma cash reserves to approximately US$86 million, and pro-forma cash and short-term assets to approximately US$117 millionPrenetics simplifies...
Moleculin Participates in Virtual Investor “What This Means” Segment
Watch the “What This Means" segment here HOUSTON, June 18, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin”...
Trualta Introduces Comprehensive Cancer Care Toolkit to its Support Platform
The Toolkit will Help Caregivers Navigate Cancer Diagnoses and Treatment KANSAS CITY, Mo., June 17, 2025 /PRNewswire/ -- Trualta, the leading family caregiver...
VA Western New York Medical Centers Supercharge Patient Care with HealthLevel’s Foundations™
MOUNTAIN VIEW, Calif., June 17, 2025 /PRNewswire/ -- HealthLevel, a leading provider of radiology analytics and workflow efficiency solutions, announced...
Genomenon Powers Groundbreaking Study on Genetic Drivers of Rare Liver Disorders
ANN ARBOR, Mich., June 17, 2025 /PRNewswire/ -- Genomenon, a leading genomic intelligence company, today announced its pivotal role in...
Ricoh establishes Ricoh 3D for Healthcare, LLC
New company accelerates point-of-care production of patient-specific 3D printed devices for hospitals EXTON, Pa., June 17, 2025 /PRNewswire/ -- With hospitals...
Ratio Therapeutics and Nusano Enter Long-Term, Multi-Isotope Supply Agreement to Boost Production of Cancer Radiopharmaceuticals
Agreement provides Ratio access to Nusano-produced radioisotopes for oncology diagnostics and therapeuticsAccelerates Ratio's clinical pipeline with copper-64 for PET imaging and...
Relmada Therapeutics Appoints Urology Expert Raj S. Pruthi, MD as CMO-Urology
Dr. Pruthi brings vast clinical development experience advancing novel therapies for NMIBC to Relmada and the NDV-01 program Phase 3...
Microbix Attending & Presenting at Asia Pacific POC 2025
Showcasing Global Utility of its QAPs at Point-of-Care Testing ConferenceMISSISSAUGA, Ontario, June 17, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc....
Breathe BioMedical Launches Second Site in Its Multi-Center Clinical Trial of Its Breath Test for Breast Cancer
Moncton, New Brunswick and Cambridge, Massachusetts--(Newsfile Corp. - June 17, 2025) - Breathe BioMedical, a company developing a breath analytics...
Ash and Impilo Partner to Deliver Seamless At-Home Health Monitoring and Testing Nationwide
NEW YORK--(BUSINESS WIRE)--Ash, a leading at-home health testing platform, and Impilo, a leader in enabling at-home healthcare through its tech-enabled...
Sona Engages Clinical Trial Clinic for First-in-Human Early Feasibility Study of its THT Cancer Therapy
First Patients Expected to be Enrolled This MonthHalifax, Nova Scotia--(Newsfile Corp. - June 16, 2025) - Sona Nanotech Inc. (CSE:...
RayStation used for pioneering clinical milestone at Helsinki University Hospital – first treatment with accelerator-based BNCT in Europe
STOCKHOLM, June 16, 2025 /PRNewswire/ -- RaySearch Laboratories AB (publ) is pleased to announce that RayStation®*, its advanced treatment planning...
Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autologous Stem Cell Transplantation (ASCT)
Media ReleaseCOPENHAGEN, Denmark; June 15, 2025 Results from the EPCORE® NHL-2 trial show investigational treatment with epcoritamab in combination with...
Investigational combination of first-in-class bispecific antibodies TALVEY®▼ (talquetamab) and TECVAYLI®▼ (teclistamab) shows deep and durable responses in heavily pretreated multiple myeloma patients with extramedullary disease
Results from the Phase 2 RedirecTT-1 study demonstrate deep responses with 78.9 percent overall response rate through dual targeting of...
Revolutionizing Diagnostics: Digital Pathology Market Growth Report | Reach US$1.73 billion by 2030 at 8.0% CAGR | The Research Insights
CHICAGO, June 13, 2025 /PRNewswire/ -- The Global Digital Pathology Market is projected to be valued at USD 1.10 billion in 2024...
Izotropic Provides Marketing Update
Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - June 13, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3)...